(Q40365204)

19 September 2017

Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis (English)

1 reference

19 September 2017

0 references

1 reference

Ai Yano

1

1 reference

19 September 2017

Kazushi Nakao

2

1 reference

19 September 2017

Ai Sarai

3

1 reference

19 September 2017

Shigeru Akagi

4

1 reference

19 September 2017

Takashi Kihara

5

1 reference

19 September 2017

Hisanori Morimoto

6

1 reference

19 September 2017

Akihiko Nakamura

7

1 reference

19 September 2017

Makoto Hiramatsu

8

1 reference

19 September 2017

Yoshio Nagake

9

1 reference

19 September 2017

Hirofumi Makino

10

1 reference

19 September 2017

1 December 2005

1 reference

19 September 2017

1 reference

19 September 2017

10

1 reference

19 September 2017

576-582

1 reference

19 September 2017

6

1 reference

The London Daily/Nocturnal Hemodialysis Study--study design, morbidity, and mortality results.

19 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Inflammatory and atherosclerotic interactions in the depleted uremic patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

New molecular aspects of chronic uraemia and dialysis-related immunocompetent cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

Increased plasma concentrations of interleukin-18 in acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00497.X

10.1111/J.1440-1797.2005.00497.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference